Navigation Links
DURECT Corporation Announces Fourth Quarter and Year End 2010 Financial Results
Date:3/2/2011

CUPERTINO, Calif., March 2, 2011 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today financial results for the three months and year ended December 31, 2010. Total revenues were $8.5 million for the three months ended December 31, 2010, up from $4.9 million for the three months ended December 31, 2009.  Net loss for the three months ended December 31, 2010 was $5.3 million, down from a net loss of $8.6 million for the same period in 2009.

(Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO)

For the fiscal year ended December 31, 2010, total revenues were $31.6 million, up from $24.5 million for the same period in 2009.  Net loss for the year ended December 31, 2010 was $22.9 million, down from a net loss of $30.3 million for the same period in 2009.

At December 31, 2010, we had cash and investments of $49.6 million, compared to cash and investments of $41.6 million at December 31, 2009.  We have no debt obligations, other than normal liabilities associated with running our business.

"2010 was a strong year for DURECT in product development and business development, with the establishment of a major collaboration around POSIDUR™ that enabled us to generate positive cash flow for the year," stated James E. Brown, D.V.M., President and CEO of DURECT.  "We look forward to the potential approval of REMOXY® in 2011 and subsequent launch by Pfizer."

Key milestones met in 2010 include:

  • Resubmission of the REMOXY NDA by King Pharmaceuticals, with an anticipated PDUFA goal date of June 23, 2011
  • Initiation of and continued enrollment in the POSIDUR U.S. pivotal Phase III trial
  • Establishment of Hospira as POSIDUR's development and commercialization partner for the U.S. and Canada
  • Commencement of a Phase IIb s
    '/>"/>

  • SOURCE DURECT Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. DURECTs Collaboration With Alpharma Clears HSR Review and Is Effective
    2. DURECT Corporation Announces Third Quarter 2008 Financial Results
    3. DURECT Corporation Invites You to Join its Third Quarter 2010 Earnings Conference Call
    4. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
    5. Pharmos Corporation Reports 2008 Second Quarter Results
    6. China Bionanometer Industries Corporation Promotes New Product Beauty Look in China
    7. Genaera Corporation Announces Second Quarter Financial Results
    8. MannKind Corporation Reports Second Quarter Financial Results
    9. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
    10. Emerging Growth Equities, Ltd. Initiates Coverage of CombiMatrix Corporation with a BUY Rating and an $18.00 Price Target
    11. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/27/2014)... MONMOUTH JUNCTION, N.J. , Aug. 27, 2014 /PRNewswire/ ... developing innovative drug delivery technologies, today announced that it ... New Jersey Business & Industry Association,s 2014 Awards ... Finalists were selected by an independent panel of judges ... member company volunteers. Award winners will be honored at ...
    (Date:8/27/2014)... BIOEQUA, an innovative line of skin ... a handheld spray, has made its EQUA ESSENTIAL line ... The brand began with an unexpected discovery in an ... learn that the application of nanospray technology allowed for ... directly to skin's basal layer. This resulted in immediate ...
    (Date:8/27/2014)... According to the 2013 Raw Material and ... and feel of markets for raw materials and ingredient ... push for more branded, science-backed products.” , Natural products ... growth in the last decade as consumers increasingly demand ... to fit a more ‘wellness’ lifestyle approach. Due ...
    (Date:8/27/2014)... (PRWEB) August 27, 2014 WriteResult, LLC ... – has once again shown superiority when it comes ... by completing the ePRO portion of their most recent ... The Japan-based pharma chose WriteResult’s digital writing platform to ... – the first to complete drew data from a ...
    Breaking Biology Technology:Tris Pharma Selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence 2BIOEQUA'S EQUA ESSENTIAL Product Line Redefines Skin Care & Now Available in America 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 3A Perfect Record: WriteResult Maintains a 100% On-Time ePRO Record with Latest Irritable Bowel (IBS) Study Data Lock 2
    ... , , WORCESTER, Mass., ... announced today that Dr. Robert Lanza, its Chief Scientific Officer, ... Dr. Michio Kaku, an hour long radio program on science, ... on public radio in New York City (WBAI 99.5 FM), ...
    ... CHERRY HILL, N.J., Sept. 21 Nuvilex, Inc. ... its joint venture partner with Reme-Flu(TM), will be incorporating Syn-X9(TM) ... a homeopathic remedy designed to help prevent and treat flu-type ... . , , The ...
    ... , , , ... (Nasdaq: VOLC ), a leader in the development, manufacturing ... and peripheral artery disease, announced today its participation in the 2009 ... 21-25. Volcano programming for TCT includes a first look at new ...
    Cached Biology Technology:Dr. Robert Lanza Featured on Michio Kaku's 'Explorations in Science' 2Dr. Robert Lanza Featured on Michio Kaku's 'Explorations in Science' 3Nuvilex, Inc. Announced that Reme-Flu(TM) will Incorporate Proprietary Syn-X9(TM) Delivery Technology into its Product Formulation 2Nuvilex, Inc. Announced that Reme-Flu(TM) will Incorporate Proprietary Syn-X9(TM) Delivery Technology into its Product Formulation 3Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics (TCT) Conference 2Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics (TCT) Conference 3Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics (TCT) Conference 4Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics (TCT) Conference 5Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics (TCT) Conference 6
    (Date:8/27/2014)... years ago a group of fish began exploring land and ... But just how these ancient fish used their fishy bodies ... were at play remain scientific mysteries. , Researchers at ... to a living fish, called Polypterus , to help ... walk out of the water. Polypterus is an ...
    (Date:8/27/2014)... requires nerve cells to rearrange existing patterns of activity ... patterns, a study of monkeys has found. The scientists ... electrical activity of brain cell networks. The study was ... "We looked into the brain and may have seen ... said Aaron Batista, Ph.D., an assistant professor at the ...
    (Date:8/27/2014)... manipulating neural circuits in the brain of mice, ... memories. The research, led by Howard Hughes Medical ... of Technology (MIT), reveals that the connections between ... information about an experience and the part of ... that experience are malleable. , Altering those ...
    Breaking Biology News(10 mins):Walking fish reveal how our ancestors evolved onto land 2Scientists plug into a learning brain 2Scientists plug into a learning brain 3Researchers change the emotional association of memories 2Researchers change the emotional association of memories 3Researchers change the emotional association of memories 4
    ... Patients suffering with end-stage renal disease could increase their ... than the conventional dialysis in clinics. A new study ... more intensive dialysis completed in a home setting. ... dialysis at home have better survival rates than patients ...
    ... Washington, D.C.The American Society for Plant Biology ... Department of Plant Biology, the Lawrence Bogorad Award ... major contributions in the development of fundamental tools ... our understanding of glucose, sucrose, ammonium, amino acid, ...
    ... Granada Department of Botanic have participated in an international ... plants to migrate to higher altitudes. The study recently ... in 66 summits of 17 European ranges between 2001 ... regions were selected in the Pyrenees (Ordesa) and Sierra ...
    Cached Biology News:Carnegie's Wolf B. Frommer receives Bogorad Award for Excellence in Plant Biology 2Global warming has driven Europe's mountain plants to migrate 2.7 meters upwards in 7 years 2
    ... Software enables you to identify over ... can distinguish protein isoforms, protein subsets, ... also visualize peptide-protein associations and relationships ... protein identification and relative protein expression ...
    ... microscopes offer all of the features of ... Equipped with Koehler illumination, a centerable condenser ... B3 is the workhorse of Motic's range ... the need for re-focusing following a change ...
    ... Green II RNA gel stain is ... has bright fluorescence when bound to RNA ... ideal for use with either formaldehyde/agarose or ... UV transilluminators. A 500 µL unit size ...
    ... SYBR Green II RNA gel stain is ... bright fluorescence when bound to RNA and low ... with either formaldehyde/agarose or polyacrylamide gels using laser ... 100 minigels. A 500 µL unit size (S-7564) ...
    Biology Products: